Page last updated: 2024-11-06

floxuridine and Telangiectasia, Hereditary Hemorrhagic

floxuridine has been researched along with Telangiectasia, Hereditary Hemorrhagic in 1 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Telangiectasia, Hereditary Hemorrhagic: An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sawabe, M1
Arai, T1
Esaki, Y1
Tsuru, M1
Fukazawa, T1
Takubo, K1

Other Studies

1 other study available for floxuridine and Telangiectasia, Hereditary Hemorrhagic

ArticleYear
Three-dimensional organization of the hepatic microvasculature in hereditary hemorrhagic telangiectasia.
    Archives of pathology & laboratory medicine, 2001, Volume: 125, Issue:9

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Angiography; Antimetabolites, Antineoplastic; Autopsy; Biop

2001